49 results on '"Briton-Jones, C."'
Search Results
2. Blastocyst collapse and downgrading of inner cell mass morphology score after vitrification-warming is predictive of reduced implantation and increased early pregnancy loss.
3. The mechanics of aneuploidy: chromosome structure and patient age.
4. Elective single embryo transfer (eSET) usage in patients at high risk of multiple pregnancies is dependent on the treating physician.
5. Low utilization of extra embryos in donor oocyte in vitro fertilization (IVF) cycles: an ethical dilemma to donor management
6. Blastulation and implantation rates of microarray CGH-defined normal embryos compared to abnormal and non-biopsied embryos
7. Prospective case cohort study showing four years of elective single embryo transfer (eSET) program: continued poor patient acceptance of eSET
8. Impact of Zona Opening on Day 3 Preimplantation Embryos on Clinical Pregnancy Rates in a Private Clinic Devoted to Assisted Reproductive Technology
9. Fertilization rate of sibling oocytes after intracytoplasmic sperm injection (ICSI) or in vitro fertilization (IVF) on primary infertility patients
10. Impact on Blastulation Potential Relative to Day 3 Cell Number at Biopsy
11. Day 3 Versus Day 5 Embryo Transfer in Women of Advanced Maternal Age
12. Donor Oocyte Recipients: A Target Group for Elective Single Embryo Transfer (eSET)
13. Characteristics of Treatment Cycles that Resulted in Monozygotic Twinning: A Case Cohort Study
14. Elevated aneuploidy rates in embryos derived from immature oocytes from controlled ovarian hyperstimulation (COH) IVF cycles
15. Are oblong shaped oocytes/embryos destined to be aneuploid?
16. Intraytoplasmic Sperm Injection (ICSI) Compared With In Vitro Fertilization (IVF) Insemination in Sibling Oocytes From Patients With Primary Unexplained Infertility and Normal Semen Analysis
17. Should Morphology Assessment Include Symmetry of Blastomeres?
18. A Role for Elective Single Embryo Transfer (E-SET) in Assisted Reproductive Medicine
19. Does post fixed nuclei morphology predict the outcome of pre-implantation genetic diagnosis-aneuploid screening?
20. Increased Aneuploidy Rates in Advanced Cell Stage Day Three Embryos
21. The effect of timing of embryonic progression on chromosomal abnormality.
22. Mineralocorticoid production by mural granulosa cells (MGCs) as a modulator of steroidogenesis during ovarian stimulation for in vitro fertilization (IVF).
23. The effect of timing of embryonic progression on chromosomal abnormality: does delayed blastulation mean more aneuploidy?
24. Fertilization Rate of Poor-Quality Sibling Oocytes after Intracytoplasmic Sperm Injection and In Vitro Fertilization
25. Pre-implantation genetic diagnosis-aneuploidy screening (PGD-AS) with 12-chromosomes studied is particularly informative compared to the 5-chromosome screen in women between 38-40 years old
26. Aneuploidy Rates in IVF Patients ≤34 Years Old Based on the Indication for Preimplantation Genetic Diagnosis Aneuploidy Screening (PGD-AS)
27. Oxidative reduction potential and sperm motility remain stable for up to two hours post-semen collection.
28. Molecular evidence demonstrates that anti-mullerian hormone predicts quantity, not quality, of oocytes.
29. Chronological age is better than physiological age at predicting likelihood of producing euploid embryos.
30. Does the number of trophectoderm cells analyzed by targeted next generation sequencing correlate with the incidence of aneuploid, mosaic or indeterminate results.
31. The incidence of mosaicism is not associated with advanced maternal age or diminished ovarian reserve.
32. In an era of euploid single embryo transfers: does oocyte age matter?
33. How does morphologic assessment correlate with implantation of euploid embryos?
34. The duration of cryostorage of biopsied embryos neither impacts implantation potential nor surrogate markers of placentation.
35. The association between aneuploidy and the rate of blastocyst development is age dependent.
36. Is reproductive potential compromised when embryos are re-biopsied?
37. How can we make a good experience even better: ways to enhance the fertility journey.
38. Aneuploidy rates are not increased in patients with recurrent pregnancy loss.
39. A high prevalence of abnormal embryos after an IVF/PGS cycle should not deter patients from pursuing a second cycle.
40. Sexual dimorphism and implantation potential: is there a difference?
41. Fertilization rates are not improved by use of ICSI versus conventional insemination in IVF cases using donor sperm.
42. Are reproductively competent blastocysts with poor morphological grade at an increased risk for adverse perinatal outcome?
43. The effect of high estradiol levels on pregnancy outcomes during in-vitro fertilization.
44. The effect of intracytoplasmic sperm injection (ICSI) on the timing of embryonic progression in cycles where oocytes were split into both ICSI and conventional insemination
45. Characterization of expression and DNA methylation patterns of H19 gene in human sertoli cells (HSEC LINE)
46. Increased blastomere numbers in cleavage stage embryos are associated with higher aneuploidy rates determined by comparative genomic hybridization
47. Peak estradiol levels do not influence pregnancy outcomes in art cycles when controlling for age, ovarian reserve parameters, and stimulation protocol
48. Does coasting in assisted reproductive technology (ART) cycles affect the number of embryos available for blastocyst cryopreservation?
49. Post-thaw survival and resumption of meiosis of immature oocytes using slow-freeze vs. vitrification methods of cryopreservation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.